Artículos con órdenes de acceso público - Mauro ZaccarelliMás información
No disponibles en ningún lugar: 17
Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients
Antiretroviral Therapy Cohort Collaboration (ART-CC
Aids 29 (3), 373-383, 2015
Órdenes: Swiss National Science Foundation, US National Institutes of Health …
Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals
D Grint, L Peters, JK Rockstroh, A Rakmanova, T Trofimova, K Lacombe, ...
Aids 29 (10), 1205-1215, 2015
Órdenes: Swiss National Science Foundation
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina
HIV/TB Study Writing Group
Aids 23 (18), 2485-2495, 2009
Órdenes: National Institute of Health and Medical Research, France
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score
A Mocroft, B Ledergerber, K Zilmer, O Kirk, B Hirschel, JP Viard, P Reiss, ...
Aids 21 (14), 1867-1875, 2007
Órdenes: Swiss National Science Foundation
Alpha, beta and gamma Human Papillomaviruses in the anal canal of HIV-infected and uninfected men who have sex with men
MG Dona, T Gheit, A Latini, M Benevolo, M Torres, V Smelov, ...
Journal of Infection 71 (1), 74-84, 2015
Órdenes: European Commission, Government of Italy
Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?
C Boesecke, D Grint, V Soriano, JD Lundgren, A d'Arminio Monforte, ...
Liver international 35 (11), 2384-2391, 2015
Órdenes: Swiss National Science Foundation
Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA
M Zaccarelli, MM Santoro, D Armenia, V Borghi, W Gennari, C Gori, ...
Journal of Clinical Virology 82, 94-100, 2016
Órdenes: Government of Italy
Deteriorating renal function and clinical outcomes in HIV-positive persons
A Mocroft, L Ryom, J Begovac, ADA Monforte, A Vassilenko, J Gatell, ...
Aids 28 (5), 727-737, 2014
Órdenes: Swiss National Science Foundation, National Institute of Health and Medical …
Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment
D Armenia, M Zaccarelli, V Borghi, W Gennari, D Di Carlo, A Giannetti, ...
Journal of Clinical Virology 104, 61-64, 2018
Órdenes: Government of Italy
Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis
D Grint, L Peters, JK Rockstroh, S De Wit, VM Mitsura, B Knysz, O Kirk, ...
Aids 28 (4), 577-587, 2014
Órdenes: Swiss National Science Foundation, National Institute of Health and Medical …
Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment
R Bellagamba, ML Giancola, C Tommasi, P Piselli, M Tempestilli, ...
Aids 33 (3), 493-502, 2019
Órdenes: Government of Italy
Prevalence and associated factors of neurocognitive impairment in HIV-positive patients on effective efavirenz/emtricitabine/tenofovir disoproxil fumarate treatment
ML Giancola, P Balestra, A Ammassari, M Ricottini, P Lorenzini, ...
AIDS Research and Human Retroviruses 34 (11), 907-908, 2018
Órdenes: Government of Italy
Incidence of pancreatitis in HIV-infected patients, and the association with antiretroviral therapy
CJ Smith, A Mocroft, JD Lundgren, EuroSIDA Study Group
AIDS 22 (8), 997-998, 2008
Órdenes: US National Institutes of Health
Immunologic response to antiretroviral therapy by age among treatment-naive patients in Sub-Saharan Africa
KA Stafford, LS Magder, LL Hungerford, JM Guralnik, SS El-Kamary, ...
Aids 32 (1), 25-34, 2018
Órdenes: US National Institutes of Health
Vaccine-preventable anal infections by human papillomavirus among HIV-infected men who have sex with men
M Giuliani, A Latini, M Colafigli, M Benevolo, F Rollo, M Zaccarelli, ...
Future Microbiology 13 (13), 1463-1472, 2018
Órdenes: Government of Italy
Interpretation of genotypic resistance to predict darunavir/ritonavir failure in antiretroviral experienced patients
G Sterrantino, M Zaccarelli, M Trotta, A De Luca, V Borghi, P Meraviglia, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (2), 170-172, 2012
Órdenes: US National Institutes of Health
Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test
M Zaccarelli, A Antinori, A Cozzi-Lepri, C Mussini, G Palamara, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 53 (1), 150-151, 2010
Órdenes: US National Institutes of Health
Disponibles en algún lugar: 64
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
Órdenes: Swiss National Science Foundation, US National Institutes of Health
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration
CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, ...
The Lancet 384 (9939), 241-248, 2014
Órdenes: UK Medical Research Council
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ...
European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010
Órdenes: Swiss National Science Foundation, US National Institutes of Health
La información de publicación y financiación se determina de forma automática mediante un programa informático